Carvedilol, a New Antihypertensive Agent, Prevents Lipid Peroxidation and Oxidative Injury to Endothelial Cells

    loading  Checking for direct PDF access through Ovid


The protective effects of carvedilol, a new β-adrenergic receptor blocker and vasodilating antihypertensive agent, against oxygen free radical–mediated injury were studied in cultured bovine endothelial cells and compared with five other β-blockers. Carvedilol dose-dependently inhibited oxygen radical–induced lipid peroxidation (50% inhibition at 2.6 μmol/L) and glutathione depletion (50% Inhibition at 1.8 μmol/L) in the cells. Under the same conditions, other β-blockers –propranolol, labetalol, pindolol, atenolol, and celiprolol –had only mild or no effect Moreover, carvedilol protected against oxygen radical–mediated cell damage, as assessed by cellular lactate dehydrogenase release, with a 50% inhibition at 4.1 μmol/L and increased the cell survival in a dose-dependent manner, whereas other β-blockers had mild or no effects. Pretreatment of the cells with carvedilol for 7 days significantly enhanced the protective effects of carvedilol. Using 2-methyl-2-nitrosopropane as a trapping agent, the spin adduct in cell lipids was monitored by electron paramagnetic resonance. Carvedilol dose-dependently decreased the intensity of the free radical signals, indicating its free radical–scavenging ability. The prevention of oxidative injury to endothelial cells might potentially contribute to the clinical beneficial effects of carvedilol as an antihypertensive agent

Related Topics

    loading  Loading Related Articles